Linked Life Data

8909320

Source:http://linkedlifedata.com/resource/pubmed/id/8909320

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1996-12-5
pubmed:abstractText
To optimize fotemustine chemotherapy, the authors considered how to combine independent Phase II trials to predict the risk of first occurrence of severe toxicity as a function of initial patient characteristics.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1980-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Logistic regression model of fotemustine toxicity combining independent phase II studies.
pubmed:affiliation
Service de Médecine Interne-Oncologie, Hôpital Saint-Antoine, Paris, France.
pubmed:publicationType
Journal Article, Meta-Analysis